Showing results (521-530 of 1,988) with videos related to
Sort By:
Pageof 199
American Journal of Respiratory and Critical Care Medicine|August 10, 2000
Prostaglandin E(2) decreases allergen-stimulated release of prostaglandin D(2) in airways of subjects with asthmaT V Hartert, R T Dworski, B G Mellen, et al.The Journal of Pharmacology and Experimental Therapeutics|August 1, 1982
Effects of indomethacin on beta adrenoreceptor-stimulated renin release in the dogE K Jackson, W A Herzer, J B Zimmerman, et al.The Journal of Pharmacology and Experimental Therapeutics|July 1, 1983
Metabolic disposition of prostacyclin in humansA R Brash, E K Jackson, C A Saggese, et al.Circulation|December 1, 1977
Suppression of ventricular ectopic depolarizations by tocainideR L Woosley, D G McDevitt, A S Nies, et al.The New England Journal of Medicine|July 9, 1981
Pharmacokinetics of indomethacin in the neonate. Relation of plasma indomethacin levels to response of the ductus arteriosusA R Brash, D E Hickey, T P Graham, et al.American Journal of Respiratory and Critical Care Medicine|October 14, 1998
Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolismA Szczeklik, R Dworski, L Mastalerz, et al.European Journal of Clinical Pharmacology|March 22, 1976
Metabolism of digitoxin in man and its modification by spironolactoneK E Wirth, J C Frölich, J W Hollifield, et al.Circulation|August 1, 1983
Electrophysiologic actions of O-demethyl encainide: an active metaboliteH J Duff, A K Dawson, D M Roden, et al.The Journal of Pharmacology and Experimental Therapeutics|January 1, 1981
6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogueE K Jackson, W A Herzer, J B Zimmerman, et al.Clinical Pharmacology and Therapeutics|April 1, 1976
Antiarrhythmic effects of a lidocaine congener, tocainide, 2-amino-2',6'-propionoxylidide, in manD G McDevitt, A S Nies, G R Wilkinson, et al.Pageof 199